![Linda Bain](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 345 463 $ in data 30/06/2026
Linda C.
Bain is currently Independent Director at Arvinas, Inc. since 2020, Non-Executive Director at Autolus Ltd., Independent Non-Executive Director at Autolus Therapeutics Plc since 2018, Director at Hemab ApS since 2022, Independent Director at Hemab Therapeutics Holdings, Inc. since 2022, and Chief Operating & Financial Officer at Mariana Oncology, Inc. since 2023.
Former positions include Independent Director at VBI Vaccines, Inc. from 2021 to 2022, VP-Finance, Global Manufacturing & Operations at Genzyme Corp.
from 2008 to 2011, Auditor at Deloitte & Touche LLP, Treasurer, CAO, VP-Finance & Business Operations at Genetix Biotherapeutics, Inc. from 2013 to 2014, Vice President at Financial Administration Services Ltd. from 2007 to 2008, Vice President-Finance at Genzyme Genetics, Inc. from 2008 to 2010, Chief Financial Officer & Treasurer at Adverum Biotechnologies, Inc. in 2015, Chief Financial Officer & Treasurer at Codiak BioSciences, Inc. from 2015 to 2023, and Vice President at Fidelity Investments, Inc. from 2007 to 2008.
Education includes undergraduate studies at The University of The Free State.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
ARVINAS, INC. 0,06% | 24/06/2026 | 41.572 ( 0,06% ) | 345 463 $ | 30/06/2026 |
| 29/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 | |
| 01/05/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| AUTOLUS THERAPEUTICS PLC | Direttore/Membro del Consiglio | 08/06/2018 |
| ARVINAS, INC. | Direttore/Membro del Consiglio | 10/06/2020 |
| HEMAB THERAPEUTICS HOLDINGS, INC. | Direttore/Membro del Consiglio | 01/01/2022 |
Autolus Ltd.
 Autolus Ltd. BiotechnologyHealth Technology Provides biopharmaceutical services | Direttore/Membro del Consiglio | - |
Hemab ApS
 Hemab ApS BiotechnologyHealth Technology Develops antibodies for the treatment of rare bleeding disorders | Direttore/Membro del Consiglio | 05/01/2022 |
Mariana Oncology, Inc.
 Mariana Oncology, Inc. BiotechnologyHealth Technology Operates as a biotechnology company pioneering a new era of radiopharmaceutical innovation to treat people with cancer | Direttore Finanziario/CFO | 09/05/2023 |
| Società | Posizione | Fine |
|---|---|---|
| CODIAK BIOSCIENCES | Direttore Finanziario/CFO | 07/04/2023 |
| VBI VACCINES INC. | Direttore/Membro del Consiglio | 09/09/2022 |
| ADVERUM BIOTECHNOLOGIES, INC. | Direttore Finanziario/CFO | 17/11/2015 |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 16 |
|---|---|
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Commercial Services |
bluebird bio, Inc.
 bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
Financial Administration Services Ltd.
 Financial Administration Services Ltd. Financial ConglomeratesFinance Provide investment portfolio management services for private individuals | Finance |
Genzyme Genetics, Inc.
 Genzyme Genetics, Inc. Medical/Nursing ServicesHealth Services Provides laboratory testing and diagnostic services | Health Services |
The University of The Free State
 The University of The Free State Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adverum Biotechnologies, Inc.
 Adverum Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells novel gene therapies | Health Technology |
Arvinas, Inc.
 Arvinas, Inc. BiotechnologyHealth Technology Engages in discovery, development and commercialization of therapies to degrade disease-causing proteins | Health Technology |
Codiak BioSciences, Inc.
 Codiak BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops exosome based therapeutics | Health Technology |
Autolus Ltd.
Autolus Ltd. BiotechnologyHealth Technology Provides biopharmaceutical services | Health Technology |
Fidelity Investments, Inc.
 Fidelity Investments, Inc. Financial ConglomeratesFinance Provides retail investment services | Finance |
VBI Vaccines, Inc.
 VBI Vaccines, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
Autolus Therapeutics Plc
 Autolus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of gene therapies | Health Technology |
Hemab ApS
Hemab ApS BiotechnologyHealth Technology Develops antibodies for the treatment of rare bleeding disorders | Health Technology |
Mariana Oncology, Inc.
Mariana Oncology, Inc. BiotechnologyHealth Technology Operates as a biotechnology company pioneering a new era of radiopharmaceutical innovation to treat people with cancer | Health Technology |
HEMAB THERAPEUTICS INC.
 HEMAB THERAPEUTICS INC. BiotechnologyHealth Technology Engages in research and development of prophylactic therapeutics for bleeding disorders | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
